South Carolina Sues Purdue Pharma For ‘Misrepresenting’ Opioid Addiction
On Tuesday morning, the state of South Carolina sued Purdue Pharma LP on the grounds of “deceptive marketing” in concern with opioid painkillers. The lawsuit was filed by South Carolina Attorney General Alan Wilson. The suit follows a similar action in the state of Ohio just a month prior.
Wilson claims that Purdue Pharma was deceptive and negligent in not conveying the addictive nature of prescription opioids to both doctors and patients, leading to an epidemic and now, “national crisis” (see below). The CDC claims there were 33,000 opioid related deaths in 2015.
“While there is atime and place for patients to receive opioids, Purdue prevented doctors and patients from receiving complete and accurate information about opioids in order to make informed choices about their treatment options,” Wilson said in a statement.
Purdue has denied any wrong-doing. Missouri, Mississippi, Ohio, Oklahoma have also sued Purdue. Additionally, residing counties in the following states have also filed suits: Tennessee, New York, Oregon, Illinois, California.
Back in 2007, Purdue pharma and three executives pleaded guilty to charges that they misbranded OxyContin, one of the most popular opioids on the market. They paid out $634.5 million sum total. In that same year, Purdue reached a $19.5 million settlement in 26 states.
President Trump held off on labeling the opioid epidemic a national crisis, stunning some and infuriating many.
Say NO To Censorship - LIKE Our Facebook Page
101 Back Pain Relief Tips
“If they don’t start, they won’t have a problem. If they do start, it’s awfully tough to get off,” Trump told reporters at the clubhouse at his private golf club. “So if we can keep them from going on — and maybe by talking to youth and telling them: ‘No good, really bad for you in every way.’ But if they don’t start, it will never be a problem.”
President Trump, in general, has softened his tone in concern with pharmaceutical companies. Originally going “all in” to challenge pharmaceutical companies and their testing standards on vaccines, the President’s rhetoric has been mostly non-existent over the matter since his formation of a “vaccine safety committee.” Pharmaceutical companies yield an extreme amount of influence with politicians, something many hope hasn’t become the case with President Trump.
The opioid crisis isn’t showing any signs of alleviating. The public at large is looking for government intervention as a way to resolve the issue. However, I do think doctors hold some responsibility in the matter, as do those who start using it recreationally. The President, in many ways, has a legitimate contention. While his action may or may not be incentivized by some sort of pharmaceutical nefarious compromise, the end result may be a libertarian-esq solution that’s best in the end. That, of course, remains to be seen.
Photo by PremierofAlberta
Author: Jim Satney
PrepForThat’s Editor and lead writer for political, survival, and weather categories.